RxPG News : Pancreatic Cancer

Multimodality approach beneficial even in advanced cancers

Thu, 13 Mar 2008 05:50:13 PST

The article published in volume 14 issue 6 of World Journal of Gastroenterology reports on one patient who presented to Dr Cosimo Sperti of University of Padua, Padova, Italy, in 2001 after an exploratory laparotomy performed in another hospital for an unresectable pancreatic cystic mass that had infiltrated the portal vein

Gemcitabine delays progression of operable pancreatic cancer

Sat, 29 Sep 2007 13:21:00 PST

Giving pancreatic cancer patients the chemotherapy drug gemcitabine after surgery delays progression of the disease by about six months, according to new research by Japanese scientists.

TG2 shields pancreatic cancer cells from self-destruction

Mon, 19 Mar 2007 22:58:03 PST

An overexpressed protein protects human pancreatic cancer cells from being forced to devour themselves, removing one of the body's natural defenses against out-of-control cell growth, researchers at The University of Texas M. D. Anderson Cancer Center report in the March issue of Molecular Cancer Research.

Liverpool to trial new pancreatic cancer therapy

Thu, 15 Mar 2007 06:08:38 PST

Patients in Liverpool are to trial a new therapy for pancreatic cancer a disease which sees most sufferers die within a year of diagnosis.

Vitamin D May Cut Pancreatic Cancer Risk by Nearly Half

Wed, 13 Sep 2006 12:00:00 PST

Consumption of Vitamin D tablets was found to cut the risk of pancreatic cancer nearly in half, according to a study led by researchers at Northwestern and Harvard universities. The findings point to Vitamin Ds potential to prevent the disease, and is one of the first known studies to use a large-scale epidemiological survey to examine the relationship between the nutrient and cancer of the pancreas. The study, led by Halcyon Skinner, Ph.D., of Northwestern, appears in the September issue of Cancer Epidemiology Biomarkers & Prevention.

Post operative gemcitabine combination therapy improves survival in pancreatic cancer

Mon, 05 Jun 2006 16:41:00 PST

Adding the cancer-fighting drug gemcitabine to standard therapy after surgery significantly improves survival for patients with the most common form of pancreatic cancer, according to a new multicenter study led by a University of Maryland radiation oncologist.

Treatment of pancreatic carcinoma by adenoviral mediated gene transfer of vasostatin in mice

Tue, 15 Nov 2005 15:10:00 PST

A gene responsible for the production of a protein called vasostatin may prove a promising new way of treating pancreatic cancer, suggests research published ahead of print in Gut.

FDA Approves Tarceva for Advanced Pancreatic Cancer

Tue, 08 Nov 2005 16:29:00 PST

Tarceva (erlotinib), the only EGFR-inhibitor to have shown a survival benefit in lung cancer, will now benefit patients with advanced pancreatic cancer following FDA approval in the United States. Pancreatic cancer is one of the most aggressive forms of the disease and kills more people within the first year than any other cancer. Tarceva is the first new treatment in a decade that has shown a significant improvement in overall survival (23%) when added to chemotherapy.

Xeloda Dramatically Extends Survival Rates in Pancreatic Cancer

Tue, 08 Nov 2005 15:28:00 PST

The interim analysis of one of the largest phase III studies investigating the first-line treatment of advanced pancreatic cancer shows that adding Xeloda(R) (capecitabine) to standard chemotherapy (gemcitabine) significantly extends patient survival.

Red Meat Associated With Pancreatic Cancer Risk

Wed, 05 Oct 2005 04:39:00 PST

High consumption of red and processed meats--but not fat or cholesterol--is associated with an increased risk of pancreatic cancer, according to a new study.

3D MRI Useful in Detecting Most Lethal Cancers

Wed, 07 Sep 2005 07:47:00 PST

3D MRI can detect pancreatic cancer when it is smaller and patients have a greater likelihood of survival, a new study shows.

New onset of hyperglycemic diabetes in adults age 50 or older - signal of underlying pancreatic cancer

Mon, 01 Aug 2005 17:00:00 PST

In a groundbreaking population-based study, researchers in Mayo Clinic Cancer Center found that new onset of hyperglycemic diabetes in adults age 50 or older may be a signal of underlying pancreatic cancer. The risk of developing the cancer within three years after a new diagnosis of diabetes is eight times higher than for the average same-age individual.

Protein responsible for unchecked cell growth found

Sun, 12 Jun 2005 05:48:00 PST

Making new strides in their ongoing effort to understand mechanisms behind the relentless growth of cancer cells, researchers at Dartmouth Medical School have found a promising key that may open doors to future treatments in pancreatic and other forms of cancer. The innovation lies in manipulating an overabundance of chemo-resistant molecules in pancreatic cancer that inactivate pathways that would normally suppress cell growth.

Disease progression model of pancreatic cancer developed

Sat, 21 May 2005 00:03:00 PST

Building on previous work, researchers at the University of Pennsylvania School of Medicine have developed an animal model of pancreatic cancer that closely mimics disease progression in humans. From this, they hope to develop new treatments for this deadly disease. Advanced pancreatic cancer is among the most lethal of cancers, with a one-year survival rate after chemotherapy of only 17 to 28 percent of patients, according to the National Cancer Institute.

Processed Meats Linked to Pancreatic Cancer

Thu, 21 Apr 2005 17:49:00 PST

Heavy consumption of hot dogs, sausages and luncheon meats, along with other forms of processed meat, was associated with the greatest risk of pancreatic cancer in a large multiethnic study reported today at the 96th Annual Meeting of the American Association for Cancer Research.

No Association Between Dietary Patterns and Pancreatic Cancer

Wed, 06 Apr 2005 17:08:00 PST

Researchers from the Harvard School of Public Health (HSPH), assessing dietary patterns among men and women and risk of pancreatic cancer, found no association with two wide-ranging dietary patterns and the risk of pancreatic cancer.